RH
Rajesh Hiralal Jaiswar
About Rajesh Hiralal Jaiswar
Data last updated:
Rajesh Hiralal Jaiswar is a Director at Novacare Hospital And Research Centre Private Limited (since 2026). Earlier, Rajesh Hiralal Jaiswar was a Director at Biozen Remedies Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novacare Hospital And Research Centre Private Limited U47721UP2026PTC250324 | Director | 20 Jul 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Biozen Remedies Private Limited U24233MH2012PTC233682 | Director | 26 Sep 2013 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Hiralal Jaiswar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shanti Jaiswar | 11815129 | Novacare Hospital And Research Centre Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Hiralal Jaiswar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Hiralal Jaiswar
Rajesh Hiralal Jaiswar currently holds 1 directorship: Novacare Hospital And Research Centre Private Limited (Director, since 20 Jul 2026).
Rajesh Hiralal Jaiswar was first appointed on 26 Sep 2013 as Director at Biozen Remedies Private Limited. The most recent appointment on record is 20 Jul 2026 at Novacare Hospital And Research Centre Private Limited.
Rajesh Hiralal Jaiswar held 1 earlier board appointment: Biozen Remedies Private Limited (Director, from 26 Sep 2013).
The current boards of Rajesh Hiralal Jaiswar's companies include Shanti Jaiswar (Novacare Hospital And Research Centre Private Limited).